BioPharm Weekly News Roundup—Week of Nov. 3, 2025

Welcome to the BioPharm International® weekly news roundup for the week of Nov. 3, 2025. In this video feature, the editors highlight each week’s industry news in an easy-to-consume, fun format. New roundups will drop every Friday, so be sure to come back each week. And be sure to check the links below for more in-depth coverage of each story.

This year’s PharmSci 360 will shine a spotlight on artificial intelligence (AI) integration and emerging technologies, including gene therapy and spatial transcriptomics, across bio/pharmaceutical research and manufacturing.

India's biotech industry is shifting from biosimilars toward novel therapies and antibody drug conjugates and is adopting flexible partnerships driven by geopolitical supply chain challenges.

Cue Biopharma and ImmunoScape aim to advance in-vivo Seed-and-Boost T-cell expansion for solid tumors, reducing complex external manufacturing and improving efficacy.

RNAnalytics offers AI-enhanced, robust nanoparticle quality control utilizing existing equipment, which is essential for personalized medicine and future RNA-based therapeutic development.